HYGEIA HC HLDGS DL-00001 (F:50I) — Market Cap & Net Worth

$13.22K USD  · €11.30K EUR  · Rank #31273

Market Cap & Net Worth: HYGEIA HC HLDGS DL-00001 (50I)

HYGEIA HC HLDGS DL-00001 (F:50I) has a market capitalization of $13.22K (€11.30K) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #31273 globally and #2841 in its home market, demonstrating a -4.69% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying HYGEIA HC HLDGS DL-00001's stock price €1.22 by its total outstanding shares 9266 (9.27K).

HYGEIA HC HLDGS DL-00001 Market Cap History: 2021 to 2026

HYGEIA HC HLDGS DL-00001's market capitalization history from 2021 to 2026. Data shows change from $56.00K to $13.22K (-23.41% CAGR).

HYGEIA HC HLDGS DL-00001 Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how HYGEIA HC HLDGS DL-00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of 50I by Market Capitalization

Companies near HYGEIA HC HLDGS DL-00001 in the global market cap rankings as of May 5, 2026.

Key companies related to HYGEIA HC HLDGS DL-00001 by market ranking:

  • HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
  • Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
  • FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
  • IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#256 HCA Holdings Inc NYSE:HCA $96.85 Billion $433.09
#962 Fresenius SE & Co. KGaA XETRA:FRE $27.16 Billion €41.25
#972 FRESENIUS SE+CO. ADR 1/4 F:FREA $26.87 Billion €10.20
#1292 IHH Healthcare Bhd KLSE:5225 $19.57 Billion RM8.82

HYGEIA HC HLDGS DL-00001 Historical Marketcap From 2021 to 2026

Between 2021 and today, HYGEIA HC HLDGS DL-00001's market cap moved from $56.00K to $ 13.22K, with a yearly change of -23.41%.

Year Market Cap Change (%)
2026 €13.22K -7.58%
2025 €14.30K -23.26%
2024 €18.63K -56.57%
2023 €42.90K -40.60%
2022 €72.22K +28.97%
2021 €56.00K --

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of HYGEIA HC HLDGS DL-00001 was reported to be:

Source Market Cap
Yahoo Finance $13.22K USD
MoneyControl $13.22K USD
MarketWatch $13.22K USD
marketcap.company $13.22K USD
Reuters $13.22K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About HYGEIA HC HLDGS DL-00001

F:50I Germany Medical Care Facilities
Market Cap
$13.22K
€11.30K EUR
Market Cap Rank
#31273 Global
#2841 in Germany
Share Price
€1.22
Change (1 day)
-1.61%
52-Week Range
€1.19 - €1.88
All Time High
€10.65
About

Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals, which offer a range of oncology healthcare and other healthcare services. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support servi… Read more